Blackhawk Capital Partners Llc. Vertex Pharmaceuticals Inc Transaction History

Blackhawk Capital Partners Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $209,241 - $246,616	-945 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $167,274 - $211,160	945 New	945 $208,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $185,380 - $207,455	-1,022 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $191,614 - $225,964	1,022 New	1,022 $220,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $49,480 - $56,858	-295 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $72,010 - $84,136	-475 Reduced 61.69%	295 $48,000
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $105,705 - $119,773	770	770 $115,000

1,721

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $115B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.